Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Filip De Keyser

From: 74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis

Contact corresponding author